Skip to main content
Brian Hess, MD, Oncology, Charleston, SC

Brian Hess MD

Breast Cancer, Hematologic Oncology, Melanoma


Physician

Join to view full profile
  • 171 Ashley AveCharleston, SC 29425

  • Phone+1 843-792-1414

Dr. Hess is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 2010 - 2013
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2010

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2016 - 2027
  • MO State Medical License
    MO State Medical License 2013 - 2017
  • IL State Medical License
    IL State Medical License 2010 - 2014
  • IL State Medical License
    IL State Medical License 2010 - 2014
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Rapid and Durable Responses with the SYK/JAK Inhibitor Cerdulatinib in a Phase
    Brian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • A Phase 2 Study of the Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Good
    Brian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Clinical Utility of Chromosomal Microarray in Establishing Clonality and High
    Brian T. Hess, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Medical Student Carries Her Lymphoma Experience with Her
    Medical Student Carries Her Lymphoma Experience with HerMarch 15th, 2023
  • Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVID
    Pre-Exposure Prophylaxis with Tixagevimab-Cilgavimab Protects Blood Cancer Patients Against COVIDDecember 16th, 2022
  • Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer Center
    Oncologist Leaves a Lasting Legacy at MUSC Hollings Cancer CenterJune 23rd, 2021

Grant Support

  • Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLLMEDICAL UNIVERSITY OF SOUTH CAROLINA2024–2029
  • A Pilot Clinical Study for a Novel Bioresorbable Bone Adhesive to Evidence Improved Cranial Flap Fixation Based on Radiographic Imaging and Patient Reported OutcomesREVBIO, INC.2024–2026
  • Commercialization of an Improved Treatment of Extremity Fractures Using a Regenerative Bone Adhesive to Accelerate Bone Healing in Aging PatientsREVBIO, INC.2023–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: